Jupiter Asset Management LTD Ligand Pharmaceuticals Inc Transaction History

Jupiter Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$74.52 - $117.06 $757,048 - $1.19 Million	-10,159 Reduced 63.84%	5,755 $512,000
Q1 2022 May 11, 2022	SELL	$94.99 - $151.56 $27,642 - $44,103	-291 Reduced 1.8%	15,914 $1.79 Million
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $204,687 - $265,857	-1,603 Reduced 9.0%	16,205 $2.53 Million
Q1 2021 May 12, 2021	SELL	$99.52 - $215.83 $1.16 Million - $2.52 Million	-11,696 Reduced 39.64%	17,808 $2.71 Million
Q4 2020 Feb 10, 2021	BUY	$80.55 - $106.05 $2.38 Million - $3.13 Million	29,504 New	29,504 $2.93 Million

276

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.06B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.